Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s share price hit a new 52-week high on Thursday. The stock traded as high as C$5.72 and last traded at C$5.64, with a volume of 70,855 shares changing hands. The stock had previously closed at C$5.31.
Medexus Pharmaceuticals Stock Performance
The firm has a 50 day simple moving average of C$5.00 and a two-hundred day simple moving average of C$4.25. The stock has a market cap of C$178.50 million, a P/E ratio of -81.14 and a beta of 0.12.
About Medexus Pharmaceuticals
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Featured Articles
- Five stocks we like better than Medexus Pharmaceuticals
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
- 3 Pharmaceutical Stocks That Offer Safety and Growth
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo-1200x675.png){kind=logo}
